1. Potential to use of viral reverse transcriptase inhibitors in oncology
    O. A. Vlasova et al, 2024, Advances in Molecular Oncology CrossRef
  2. Novel Cell Receptor System of Eukaryotes Formed by Previously Unknown Nucleic Acid-Based Receptors
    Victor Tetz et al, 2022, Receptors CrossRef
  3. Drug rechanneling: A novel paradigm for cancer treatment
    Itishree Kaushik et al, 2021, Seminars in Cancer Biology CrossRef
  4. Lamivudine, Doravirine, and Cabotegravir Downregulate the Expression of Human Endogenous Retroviruses (HERVs), Inhibit Cell Growth, and Reduce Invasive Capability in Melanoma Cell Lines
    Valentina Zanrè et al, 2024, International Journal of Molecular Sciences CrossRef
  5. Targeting hallmarks of cancer to enhance radiosensitivity in gastrointestinal cancers
    Amy M. Buckley et al, 2020, Nature Reviews Gastroenterology & Hepatology CrossRef
  6. Computational and biological approaches in repurposing ribavirin for lung cancer treatment: Unveiling antitumorigenic strategies
    Keshav Raj Paudel et al, 2024, Life Sciences CrossRef
  7. Putative Repurposing of Lamivudine, a Nucleoside/Nucleotide Analogue and Antiretroviral to Improve the Outcome of Cancer and COVID-19 Patients
    José J. García-Trejo et al, 2021, Frontiers in Oncology CrossRef
  8. A single-step O-glycosylation of azidothymidine in bioreactor catalysed by filamentous fungi
    Evilanna L. Arruda et al, 2016, Tetrahedron Letters CrossRef
  9. Favipiravir, an antiviral drug, in combination with tamoxifen exerts synergistic effect in tamoxifen-resistant breast cancer cells via hTERT inhibition
    Sally A. Fahim et al, 2024, Scientific Reports CrossRef
  10. Abacavir induces the transcriptional activity of YY1 and other oncogenic transcription factors in gastric cancer cells
    Ponmathi Panneerpandian et al, 2020, Antiviral Research CrossRef
  11. The Anti-Angiogenic Effects of Anti-Human Immunodeficiency Virus Drugs
    Giovanni Barillari, 2020, Frontiers in Oncology CrossRef
  12. Drug repurposing: re-inventing therapies for cancer without re-entering the development pipeline—a review
    Shafina Siddiqui et al, 2022, Journal of the Egyptian National Cancer Institute CrossRef
  13. Repurposed Drugs in Gastric Cancer
    Diana Araújo et al, 2022, Molecules CrossRef